Acrivon TherapeuticsACRV
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 48 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, down 5 from Q2 2025. 6 opened new positions and 11 sold out. The largest holders were Ra Capital Management, L.P. ($15.1M), Sands Capital Alternatives, LLC ($3.8M) and Citadel Advisors ($2.8M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.3M |
| Exits | 11 | $857K |
All 13F filers, Q2 2025 → Q3 2025: 1,310,511 shares bought and 1,589,961 shares sold, net −279,450 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Ra Capital Management, L.P. | 0.19% | No change | 8,340,508 | $15.1M |
| Sands Capital Alternatives, LLC | 0.84% | No change | 2,122,605 | $3.8M |
| Citadel Advisors | 0.00% | Reduce -18.7% | 1,541,326 | $2.8M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $1.6M |
| UBS Group AG | 0.00% | Add +150057.8% | 683,218 | $1.2M |
| Vanguard Group Inc. | 0.00% | Add +5.5% | 626,148 | $1.1M |
| Renaissance Technologies | 0.00% | Add +22.4% | 623,400 | $1.1M |
| Focus Partners Wealth | 0.00% | New | 19,846 | $988K |
| Acorn Capital Advisors, LLC | 0.37% | No change | 405,237 | $733K |
| BlackRock, Inc. | 0.00% | Reduce -18.8% | 330,957 | $599K |
| Two Sigma Investments, LP | 0.00% | Add +76.2% | 319,205 | $578K |
| Jane Street Group, LLC | 0.00% | Reduce -7.2% | 289,248 | $524K |
| Geode Capital Management, LLC | 0.00% | Add +16.8% | 192,033 | $348K |
| Millennium Management | 0.00% | Reduce -37.5% | 185,234 | $335K |
| Marshall Wace, LLP | 0.00% | Reduce -17.4% | 149,715 | $271K |
| Two Sigma Advisers, LP | 0.00% | Add +318.7% | 136,500 | $247K |
| Squarepoint Ops LLC | 0.00% | Reduce -31.6% | 104,324 | $189K |
| Acadian Asset Management LLC | 0.00% | New | 92,004 | $165K |
| State Street Corp. | 0.00% | No change | 67,145 | $122K |
| Morgan Stanley | 0.00% | Reduce -9.3% | 57,160 | $103K |
| Algert Global LLC | 0.00% | New | 44,648 | $81K |
| Northern Trust Corp. | 0.00% | Reduce -9.9% | 42,166 | $76K |
| Bluefin Capital Management, LLC | 0.04% | New | 42,039 | $76K |
| XTX Topco Ltd | 0.00% | Reduce -66.1% | 35,955 | $65K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 22,900 | $41K |
| Baker Bros. Advisors LP | 0.00% | No change | 22,809 | $41K |
| Barclays PLC | 0.00% | Reduce -4.6% | 19,965 | $36K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -85.9% | 19,742 | $36K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -11.8% | 19,579 | $35K |
| Bank of America Corp. | 0.00% | Reduce -8.3% | 18,904 | $34K |
| Citigroup Inc. | 0.00% | Reduce -49.6% | 16,305 | $30K |
| AAF Wealth Management, LLC | 0.01% | New | 10,678 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.2% | 8,736 | $16K |
| FMR LLC | 0.00% | Reduce -12.5% | 8,622 | $16K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -12.4% | 5,514 | $10K |
| Federated Hermes, Inc. | 0.00% | Add +4.7% | 2,426 | $4K |
| JPMorgan Chase & Co. | 0.00% | Add +22.8% | 1,741 | $3K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +0.4% | 1,216 | $2K |
| BNP Paribas Financial Markets | 0.00% | Add +19.9% | 1,189 | $2K |
| Royal Bank of Canada | 0.00% | Add +2958.1% | 948 | $2K |
| GF Fund Management Co. LTD. | 0.00% | Reduce -15.8% | 650 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | No change | 584 | $1K |
| Redwood Park Advisors LLC | 0.00% | No change | 500 | $905 |
| Russell Investments Group, Ltd. | 0.00% | No change | 481 | $871 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $724 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 373 | $675 |
| SBI Securities Co., Ltd. | 0.00% | No change | 74 | $134 |
| Cwm, LLC | 0.00% | Reduce -83.9% | 127 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.